|
VILAC
2010 - January 28TH
2010 |
|
Statistical Analysis Cycle-I Jan 20th – Jan 27th 2010 |
Parameter |
Units |
Group Mean |
S.D. |
|
SDI |
|
Biochemistry |
| Urea |
mg/dL |
137 |
14 |
-- |
-- |
| Creatinine |
mg/dL |
5.0 |
0.4 |
-- |
-- |
| Uric
Acid |
mg/dL |
10.1 |
0.8 |
-- |
-- |
| Cholesterol |
mg/dL |
224 |
15 |
-- |
-- |
| HDL
Chol |
mg/dL |
94 |
13 |
-- |
-- |
| Triglycerides |
mg/dL |
252 |
21 |
-- |
-- |
| Bilirubin |
mg/dL |
4.4 |
0.5 |
-- |
-- |
| SGOT |
U/L |
138 |
13 |
-- |
-- |
| Calcium |
mg/dL |
13.2 |
1.2 |
-- |
-- |
| Inor
Phos |
mg/dL |
9.1 |
1.3 |
-- |
-- |
| Protein |
g/dL |
5.3 |
0.4 |
-- |
-- |
| Glucose |
mg/dL |
221 |
17 |
-- |
-- |
|
Hematology |
| HB |
g/dL |
13.2 |
0.5 |
-- |
-- |
| TLC |
per
cumm |
9012 |
640 |
-- |
-- |
| TRBC |
mill/cumm |
4.2 |
0.2 |
-- |
-- |
| Platelet |
thous/cumm |
278 |
24.1 |
-- |
-- |
| Blood
Group |
ABO |
B |
-- |
-- |
-- |
| Rh |
Pos/Neg |
+ |
-- |
-- |
-- |
|
Immunoassays
/ Special Tests - Participation
in at least 3 parameters
Mandatory |
| HbA1C |
% |
4.8 |
0.5 |
-- |
-- |
| HbA2 |
% |
2.9 |
0.3 |
-- |
-- |
| TSH |
uIU/mL |
1.2 |
0.2 |
-- |
-- |
| Prolactin |
ng/mL |
5.4 |
1.0 |
-- |
-- |
| Testosterone |
ng/mL |
1.0 |
0.5 |
-- |
-- |
| PSA |
ng/mL |
1.7 |
0.4 |
-- |
-- | |
Please inform about any transcription
error with in 48 hours.
| Standard Deviation
Index: |
Interpretation of
SDI: |
| Standard Deviation Index (SDI)
should be
calculated by participant. |
0.0 –
0.5
Excellent |
| 0.5 –
1.0
Good |
 |
1.0 –
2.0
Acceptable |
|
2.0 &
above
Needs Improvement |
|
3.0 and
above Urgent
Action
required |
Dr. Rakesh
Sharma
Chief Coordinator
& Organizer VILAC
| VILAC
Micro Statistical
Analysis Cycle - IV
|
| November 14th –November 20th |
| 1.
Organism Identification and Sensitivity
Testing |
| Organism
Sent |
E
coli (Ref Strain From
MTCC) |
| Organism Isolated by
majority of Participants |
-- |
| Organism Isolated by
participant |
-- |
| |
| Sensitivity
Pattern |
Sensitivity Pattern
of organism sent Sensitive /
Resistant |
Sensitivity Result
Observed By the
Participant |
| Ampicillin |
Sensitive |
-- |
| Chloramphenicol |
Sensitive |
-- |
| Cotrimoxazole |
Sensitive |
-- |
| Gentamicin |
Sensitive |
-- |
| Ofloxacin |
Sensitive |
-- |
| Tetracycline |
Sensitive |
-- |
|
2.
Immunoassays:
Microbiology |
| Immunoassays:
Microbiology |
| Parameters
(Qualitative) |
Consensus
Interpretation |
Observed
By the Participant |
| 1.Rubella
IgG |
Positive |
-- |
| 2.Cytomegalovirus
IgG |
Positive |
-- |
| 3.ToxoplasmaIgG |
Negative |
-- |
Dr. Rakesh
Sharma
Chief Coordinator
& Organizer VILAC |
